• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    More On SNTS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Santarus, Inc. (SNTS)

    -NasdaqGS
    31.96 0.00(0.00%) Dec 31
    |After Hours : 31.96 0.00 (0.00%) 4:23PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:31.96
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:32.00
    Beta:1.66
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:19,400.00 - 25,000.00
    Volume:0
    Avg Vol (3m):11,238
    Market Cap:N/A
    P/E (ttm):19.13
    EPS (ttm):1.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ยป More Headlines for SNTS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-13) :N/A
    Quarterly EPS Est (Dec-13) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Santarus, Inc., a specialty biopharmaceutical company, focuses on acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback